Stock Exchange Communication


IN THIS SECTION

Stock Exchange Intimations

April
29 April, 2024

Re-appointment of Directors of the Company

29 April, 2024

Outcome of the Board Meeting dated April 29, 2024: Approval of Audited Consolidated and Standalone Financial Results of the Company for the fourth quarter and year ended March 31, 2024

29 April, 2024

Outcome of the Board Meeting dated April 29, 2024: Recommendation of Dividend for Financial Year 2023-24

29 April, 2024

Press Release - Audited Consolidated and Standalone Financial Results of the Company for the quarter and financial year ended March 31, 2024

29 April, 2024

Analysts/ Investors presentation dated April 29, 2024 for the Audited Consolidated and Standalone financial results of the Company for the quarter and financial year ended March 31, 2024

28 April, 2024

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Shareholding Pattern

Shareholding Pattern as on March 31, 2024

Shareholding Pattern as on December 31, 2023

Shareholding pattern as on September 30, 2023

Shareholding pattern as on June 30, 2023

Quarterly Corporate Governance Reports

Corporate Governance Report as on March 31, 2024

Corporate Governance Report as on December 31, 2023

Corporate Governance Report as on September 30, 2023

Corporate Governance Report as on June 30, 2023

Related Party Transactions

Disclosure of Related Party Transactions for the half year ended September 30, 2023 pursuant to SEBI Regulations

Investors Contact

Rajiv Chandan

Chief General Counsel & Company Secretary

Phone

91-22-66658282

Damini Jhunjhunwala

Assistant General Manager – Strategic Finance & Risk Management

Phone

91-22-66657405

Tata Chemicals Limited

Registered Office

24, Bombay House, Homi Mody Street, Fort, Mumbai 400 001, India

CIN: L24239MH1939PLC002893